申请人:Merck & Co., Inc.
公开号:EP0367601A1
公开(公告)日:1990-05-09
Compounds having the formula:
wherein R¹ is -NH(C=O)OR⁵, -NH(C=NH)NH₂ or -NH(C=N-NO₂)HN₂; R² is hydrogen, C₁₋₈alkyl or C₆₋₈aryl; n is 2 to 6; and R⁵ is hydrogen, C₁₋₈alkyl, C₆₋₈aryl, or C₇₋₈alkaryl; are disclosed in addition to methods to employ such compounds to induce migration of endothelial cells into denuded areas of vessel lining and to treat malignant hypercalcemia.
具有以下式子的化合物
其中R¹是-NH(C=O)OR⁵、-NH(C=NH)NH₂或-NH(C=N-NO₂)HN₂;R²是氢、C₁₋₈烷基或C₆₋₈烷基;n是2至6;R⁵是氢、C₁₋₈烷基、C₆₋₈烷基或C₇₋₈烷芳基;公开了使用这些化合物诱导内皮细胞迁移到血管内膜剥脱区域和治疗恶性高钙血症的方法。